Quarterly report pursuant to Section 13 or 15(d)

Stockholders??? Equity (Deficit) (Details Narrative)

Stockholders’ Equity (Deficit) (Details Narrative) - USD ($) $ / shares in Units, $ in Thousands	1 Months Ended				3 Months Ended		6 Months Ended
	Mar. 31, 2022	Feb. 28, 2022	Jan. 31, 2022	Aug. 31, 2021	Jun. 30, 2022	Mar. 31, 2022	Jun. 30, 2023	Jun. 30, 2022	Dec. 31, 2022
Subsidiary, Sale of Stock [Line Items]
Common stock shares, outstanding							15,016,295		15,016,295
Proceeds from warrant exercises								$ 4
Stock-based compensation							$ 554	497
Common Stock [Member]
Subsidiary, Sale of Stock [Line Items]
Issuance of common stock, net (in shares)						1,151,000
Common Stock [Member] \| Restricted stock agreement with Maxim Group, LLC [Member]
Subsidiary, Sale of Stock [Line Items]
Number of shares agreed to issue				50,000
Vesting period				12 months
Stock-based compensation					$ 27			$ 54
JT Pharmaceuticals [Member]
Subsidiary, Sale of Stock [Line Items]
Issuance of common stock, net (in shares)			51,021
Milestone payment			$ 100
Pre-Funded Warrants [Member]
Subsidiary, Sale of Stock [Line Items]
Number of warrants issued	974,242					974,242
Proceeds from warrant exercises	$ 1
February 2022 Offerings [Member]
Subsidiary, Sale of Stock [Line Items]
Issuance of common stock, net (in shares)		1,100,000
Proceeds from sale of common stock		$ 5,000
February 2022 Offerings [Member] \| Pre-Funded Warrants [Member]
Subsidiary, Sale of Stock [Line Items]
Number of warrants issued		2,274,242
Exercise price of warrants (in dollars per share)		$ 0.001
February 2022 Offerings [Member] \| Unregistered prefunded warrants [Member]
Subsidiary, Sale of Stock [Line Items]
Number of warrants issued		1,289,796
Exercise price of warrants (in dollars per share)		$ 0.001
February 2022 Offerings [Member] \| Unregistered five year and six month warrants [Member]
Subsidiary, Sale of Stock [Line Items]
Number of warrants issued		4,664,038
Exercise price of warrants (in dollars per share)		$ 1.14
N 2015 Omnibus Equity Incentive Plan [Member]
Subsidiary, Sale of Stock [Line Items]
Number of shares agreed to issue							2,500,000